When.com Web Search

  1. Ads

    related to: dulera inhaler alternatives for covid 19

Search results

  1. Results From The WOW.Com Content Network
  2. FDA approves generic to commonly used inhaler as demand ... - AOL

    www.aol.com/news/fda-approves-generic-commonly...

    The U.S Food and Drug Administration on Wednesday approved https://reut.rs/2RnpE3h first generic of a commonly used albuterol sulfate-based inhaler, catering to increased demand from COVID-19 ...

  3. Mometasone/formoterol - Wikipedia

    en.wikipedia.org/wiki/Mometasone/formoterol

    Mometasone/formoterol, sold under the brand name Dulera among others, is a fixed-dose combination medication used in the long-term treatment of asthma. [1] It contains mometasone a steroid and formoterol a long-acting beta agonist. [1] It is only recommended in those for whom an inhaled steroid is not sufficient. [1] It is used by inhalation. [1]

  4. Treatment and management of COVID-19 - Wikipedia

    en.wikipedia.org/wiki/Treatment_and_management...

    This registry based, multi-center, multi-country data provide provisional support for the use of ECMO for COVID-19 associated acute hypoxemic respiratory failure. Given that this is a complex technology that can be resource intense, guidelines exist for the use of ECMO during the COVID-19 pandemic. [85] [86] [87]

  5. Budesonide - Wikipedia

    en.wikipedia.org/wiki/Budesonide

    After a University of Oxford research team found in a trial with 1,700 patients that budesonide could benefit many people over 50 with COVID-19 symptoms, it was recommended from 12 April 2021, by the National Health Service in the UK for general practitioners (GPs) to treat COVID-19 on a case-by-case basis.

  6. Parents search for Flovent alternatives as childhood asthma ...

    www.aol.com/parents-search-flovent-alternatives...

    Flovent, one of the most commonly prescribed childhood asthma inhalers, is no longer being manufactured in the United States. This preventative medication is usually taken every day to help keep ...

  7. Some drugmakers to cap cost of asthma inhalers at $35 a month

    www.aol.com/news/drugmakers-cap-cost-asthma...

    Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim.